A Retrospective Multicenter Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy
Phase of Trial: Phase IV
Latest Information Update: 20 Oct 2017
At a glance
- Drugs Perampanel (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- Sponsors Eisai Inc
- 19 Sep 2017 Planned End Date changed from 1 Apr 2019 to 1 May 2019.
- 19 Sep 2017 Planned primary completion date changed from 1 Mar 2019 to 1 Apr 2019.
- 07 Jul 2017 New trial record